Expanding the Healthcare Support Business and Generating Operating Profit Consistently
First written in FY2016. 22 of 36 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「During the current consolidated fiscal year, the company maintained a stable order base for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services, while contracts from new customers steadily increased. It recognized ¥786 million in revenue, up 14.3% year on year.」
Contracts with new customers increased while the stable order base was maintained, resulting in revenue of ¥786 million and operating profit of ¥160 million. - FY2026-H1AdvancedAnnual report
「During the current interim consolidated accounting period, the company maintained a stable order base for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services, while contracts from new customers steadily increased. It recognized ¥460 million in revenue, up 17.2% year on year. Orders also totaled ¥460 million, up 17.2%, and there was no order backlog at the end of the current interim consolidated accounting period, as was the case at the end of the year-earlier period. Order intake for this business is determined mainly retrospectively based on results achieved in specific health guidance and other services, and is therefore recognized when those results are finalized rather than when contracts are signed. Accordingly, the Healthcare Support business reported revenue of ¥460 million, up 17.2% year on year, and operating profit of ¥74 million, up 89.5%.」
Contracts with new customers increased while the stable order base was maintained, resulting in 17.2% year-on-year increases in revenue and orders, and an 89.5% increase in operating profit. Progress toward continued operating profit generation is evident. - FY2025AdvancedAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥688 million, up 15.7% year on year, and operating profit of ¥106 million, up 15.3%.」
The business maintained a stable order base for specific health guidance and related services, while contracts from new customers also increased. As a result, both revenue and operating profit increased, and the business remained profitable. - FY2025-H1Revenue increased and profit declined, but operating profit remained positiveAnnual report
「During the current interim consolidated accounting period, the company recognized ¥392 million in revenue, up 16.4% year on year, from fees for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services. Accordingly, the Healthcare Support business reported revenue of ¥392 million, up 16.4% year on year, and operating profit of ¥39 million, down 7.5%.」
Revenue from specific health guidance and related services increased, while operating profit declined 7.5% year on year. However, operating profit of ¥39 million was generated and the business remained profitable. - FY2024Revenue increased and profit declined, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥594 million, up 7.6% year on year, and operating profit of ¥92 million, down 0.7%.」
The Healthcare Support business increased revenue and remained profitable, while operating profit fell below the year-earlier period. Progress toward business expansion and continued operating profit generation was mixed. - FY2024-Q3Revenue increased and profit declined, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥490 million, up 5.8% year on year, and operating profit of ¥77 million, down 6.6%.」
Revenue from specific health guidance, support for specific health checkups, diabetes complication prevention and claims analysis increased, while operating profit fell below the year-earlier period. However, the business remained profitable. - FY2024-Q2Revenue increased and profit declined, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥337 million, up 7.3% year on year, and operating profit of ¥42 million, down 6.2%.」
Revenue from specific health guidance, support for specific health checkups, diabetes complication prevention and claims analysis increased, while operating profit fell below the year-earlier period. However, the business remained profitable. - FY2024-Q1Revenue increased and profit declined, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥157 million, up 6.6% year on year, and operating profit of ¥10 million, down 28.2%.」
The Healthcare Support business increased revenue, while operating profit fell below the year-earlier period. However, it remained profitable. - FY2023Slight revenue increase and profit decline, but operating profit remained positiveAnnual report
「During the current consolidated fiscal year, the company recognized ¥552 million in revenue, up 0.8% year on year, from fees for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services.」
The Healthcare Support business reported a slight increase in revenue, while operating profit was ¥93 million, down 20.5% year on year. However, the business remained profitable for the full fiscal year. - FY2023-Q3Revenue increased and profit declined, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥463 million, up 2.3% year on year, and operating profit of ¥83 million, down 6.5%.」
The Healthcare Support business increased revenue, while operating profit fell below the year-earlier period. However, it remained profitable. - FY2023-Q2Slight revenue and profit declines, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥314 million, down 0.2% year on year, and operating profit of ¥45 million, down 12.2%.」
The Healthcare Support business reported slight revenue and profit declines, but generated operating profit of ¥45 million and remained profitable. - FY2023-Q1Slight revenue and profit declines, but operating profit remained positiveAnnual report
「Accordingly, the Healthcare Support business reported revenue of ¥147 million, down 0.7% year on year, and operating profit of ¥15 million, down 30.4%.」
The Healthcare Support business reported slight revenue and profit declines, but generated operating profit of ¥15 million and remained profitable. - FY2022-Q3AdvancedAnnual report
「During the third quarter of the current consolidated cumulative period, the number of services provided continued to trend upward, driven by an increase in contracted health insurance societies and other factors. The company recognized ¥452 million in revenue, up 33.2% year on year, from fees for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services. Accordingly, the Healthcare Support business reported revenue of ¥452 million, up 33.2% year on year, and operating profit of ¥88 million, up 200.9%.」
The number of services provided increased due to growth in contracted health insurance societies and other factors, and both revenue and operating profit exceeded the year-earlier period. Progress toward business expansion and continued operating profit generation remains ongoing. - FY2022-Q2AdvancedAnnual report
「During the second quarter of the current consolidated cumulative period, the number of services provided continued to trend upward, driven by an increase in contracted health insurance societies and other factors. The company recognized ¥314 million in revenue, up 49.3% year on year, from fees for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services.」
The number of services provided increased against a backdrop of growth in contracted health insurance societies and other factors, with revenue reaching ¥314 million, up 49.3% year on year. Operating profit also reached ¥51 million, up 327.6%, indicating progress in business expansion and continued profit generation. - FY2022-Q1AdvancedAnnual report
「During the first quarter of the current consolidated cumulative period, the company recognized ¥148 million in revenue, up 75.8% year on year, from fees for outsourced specific health guidance, support for specific health checkups for dependents, diabetes complication prevention services, claims analysis and other services.」
Revenue from specific health guidance and related services increased 75.8% year on year to ¥148 million, while operating profit increased 269.3% to ¥21 million. The figures indicate progress in business expansion and profit generation. - FY2021-Q3Revenue and profit declined, but operating profit remained positiveAnnual report
「During the third quarter of the current consolidated cumulative period, schedules for regular health checkups, specific health checkups and specific health guidance were delayed due to the spread of COVID-19. As a result, revenue recognized from fees for these outsourced services declined from the year-earlier period, among other factors, and revenue from the business was ¥340 million, down 1.0% year on year. Accordingly, the Healthcare Support business reported revenue of ¥340 million, down 1.0% year on year, and operating profit of ¥29 million, down 11.7%.」
Revenue and profit declined due to delays in health checkup and health guidance schedules caused by the impact of infectious diseases, but revenue of ¥340 million and operating profit of ¥29 million were generated, and the business remained profitable. - FY2021-Q2Revenue and profit declined due to the impact of infectious diseases, but operating profit remained positiveAnnual report
「During the second quarter of the current consolidated cumulative period, schedules for regular health checkups, specific health checkups and specific health guidance were delayed due to the spread of COVID-19. As a result, revenue recognized from fees for these outsourced services declined from the year-earlier period, among other factors, and revenue from the business was ¥210 million, down 9.6% year on year. Accordingly, the Healthcare Support business reported revenue of ¥210 million, down 9.6% year on year, and operating profit of ¥12 million, down 27.0%.」
Revenue and profit declined due to delays in health checkup and health guidance schedules caused by the spread of infectious diseases, but operating profit of ¥12 million was generated and the business remained profitable. - FY2021-Q1Revenue and profit declined due to the impact of infectious diseases, but operating profit remained positiveAnnual report
「During the first quarter of the current consolidated cumulative period, schedules for regular health checkups, specific health checkups and specific health guidance were delayed due to the spread of COVID-19. As a result, revenue recognized from fees for these outsourced services declined from the year-earlier period, among other factors, and revenue from the business was ¥84 million, down 19.1% year on year. Accordingly, the Healthcare Support business reported revenue of ¥84 million, down 19.1% year on year, and operating profit of ¥5 million, down 23.5%.」
Revenue and profit declined due to delays in health checkup and health guidance schedules caused by the spread of infectious diseases, but operating profit of ¥5 million was generated and the business remained profitable. - FY2020AdvancedAnnual report
「In the current consolidated fiscal year, the Healthcare Support business reported a 13.1% year-on-year increase in revenue and, as in the previous fiscal year, generated operating profit. The company intends to continue generating operating profit by further expanding the business and improving operational efficiency.」
Revenue was ¥408 million and operating profit was ¥43 million, resulting in full-year operating profit for the second consecutive fiscal year. Progress is being made toward continued profit generation through business expansion and efficiency improvements. - FY2020-Q3AdvancedAnnual report
「As a result, the healthcare support business posted revenue of ¥343 million, up 13.5% year on year, and operating profit of ¥33 million, up 7.5% year on year.」
Revenue and operating profit from specific health guidance, support for specific health checkups, diabetes complication prevention, claims analysis and other services exceeded the year-earlier period, with business expansion and continued operating profit generation. - FY2020-Q2AdvancedAnnual report
「During the six months ended the second quarter of the current consolidated fiscal year, we recognized revenue of ¥233 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 14.4% year on year. As a result, the healthcare support business posted revenue of ¥233 million, up 14.4% year on year, and operating profit of ¥16 million, down 3.6% year on year.」
Revenue from services including specified health guidance increased 14.4% year on year, and the business also generated operating profit of ¥16 million. Revenue growth and profit generation continued, while profit fell below the same period of the previous year. - FY2020-Q1AdvancedAnnual report
「During the three months ended the first quarter of the current consolidated fiscal year, we recognized revenue of ¥104 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 18.6% year on year.」
Revenue from services including specified health guidance increased 18.6% year on year, and operating profit in the healthcare support business was ¥7 million, up 44.4% year on year. The figures indicate progress in business expansion and profit generation. - FY2019AdvancedAnnual report
「The healthcare support business reported revenue up 26.7% from the previous fiscal year and continued to generate operating profit, as it did in the previous fiscal year. Our policy is to pursue continued operating profit generation by further expanding the business and working to improve operational efficiency.」
Revenue increased 26.7% from the previous fiscal year to ¥361 million, while operating profit was ¥38 million, achieving full-year operating profit generation for the second consecutive fiscal year. The company also reiterated its policy of continued profit generation through business expansion and improved efficiency. - FY2019-Q3AdvancedAnnual report
「As a result, the healthcare support business posted revenue of ¥302 million, up 30.4% year on year, and operating profit of ¥31 million, up 185.1% year on year.」
Revenue from services including specified health guidance increased 30.4% year on year, while operating profit also rose to ¥31 million, up 185.1%. Progress toward business expansion and continued operating profit generation continued. - FY2019-Q2AdvancedAnnual report
「As a result, the healthcare support business posted revenue of ¥204 million, up 49.6% year on year, and operating profit of ¥17 million, compared with an operating loss of ¥1 million in the same period of the previous year.」
Revenue from services including specified health guidance increased 49.6% year on year, and the business moved from an operating loss to an operating profit. The figures indicate progress toward business expansion and continued operating profit generation. - FY2019-Q1AdvancedAnnual report
「During the three months ended the first quarter of the current consolidated fiscal year, we recognized revenue of ¥88 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 58.1% year on year.」
Revenue from services including specified health guidance increased 58.1% year on year to ¥88 million, and the healthcare support business moved from an operating loss of ¥3 million in the same period of the previous year to operating profit of ¥5 million. - FY2018AdvancedAnnual report
「For the current consolidated fiscal year, the business reported revenue up 11.1% from the previous fiscal year and continued to generate operating profit. Our policy is to pursue continued operating profit generation by further expanding the business and working to improve operational efficiency.」
The healthcare support business generated revenue of ¥285 million and operating profit of ¥12 million, continuing to report higher revenue and operating profit. However, operating profit was down 42.9% year on year, so the target was not fully achieved. - FY2018-Q3AdvancedAnnual report
「During the nine months ended the third quarter of the current consolidated fiscal year, we recognized revenue of ¥232 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 15.2% year on year. The business reported higher revenue, primarily due to a large order, but profit declined due to higher personnel expenses and other factors. As a result, the healthcare support business posted revenue of ¥232 million, up 15.2% year on year, and operating profit of ¥10 million, down 20.1% year on year.」
Revenue increased 15.2% year on year, mainly due to a large order, and the business moved from an operating loss at the six-month point to operating profit of ¥10 million. However, profit declined year on year, so progress toward continued operating profit generation remains mixed. - FY2018-Q2Slight revenue growth, but a move into the redAnnual report
「During the six months ended the second quarter of the current consolidated fiscal year, we recognized revenue of ¥136 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 1.0% year on year. As a result, the healthcare support business posted revenue of ¥136 million, up 1.0% year on year, and an operating loss of ¥1 million, compared with operating profit of ¥0 million in the same period of the previous year.」
Revenue from services including specified health guidance edged up 1.0% year on year, while the business moved from operating profit in the same period of the previous year to an operating loss of ¥1 million, weakening the outlook for continued operating profit generation. - FY2018-Q1AdvancedAnnual report
「During the three months ended the first quarter of the current consolidated fiscal year, we recognized revenue of ¥55 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 58.2% year on year.」
Revenue from services including specified health guidance increased 58.2% year on year, while the operating loss narrowed from ¥5 million in the same period of the previous year to ¥3 million. Although the business has not yet achieved continued operating profit generation, progress is evident in expansion and improved profitability. - FY2017-Q3AdvancedAnnual report
「During the nine months ended the third quarter of the current consolidated fiscal year, we recognized revenue of ¥201 million from commissions for specified health guidance, support for specified health checkups for dependents, services to prevent severe diabetes, claims analysis and related services, up 69.4% year on year. Orders received also totaled ¥201 million, up 69.4% year on year, while there was no order backlog at the end of the third quarter of the current consolidated fiscal year, compared with none at the end of the same period of the previous year. Orders received in this business are determined mainly after the fact based on results such as the provision of specified health guidance, and are therefore recognized when those results are finalized rather than when contracts are signed. As a result, the healthcare support business posted revenue of ¥201 million, up 69.4% year on year, and operating profit of ¥13 million, compared with an operating loss of ¥2 million in the same period of the previous year.」
Revenue from services including specified health guidance increased 69.4% year on year, and the business moved from an operating loss to an operating profit. The figures indicate progress toward business expansion and continued operating profit generation. - FY2016First statedAnnual report
「We plan to expand the business further and improve operating efficiency, with the aim of generating operating profit on a continuing basis.」
The group has set out plans to expand specified health guidance, health-checkup support, diabetes complication prevention and claims-data analysis, while improving operating efficiency.